(Q45928991)

17 December 2017

title

Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB. (English)

1 reference

17 December 2017

1 reference

Carmine D'Acunto

1

1 reference

17 December 2017

Carlotta Gurioli

series ordinal

2

1 reference

17 December 2017

Iria Neri

series ordinal

3

1 reference

17 December 2017

publication date

1 January 2010

1 reference

17 December 2017

Journal of Dermatological Treatment

published in

1 reference

17 December 2017

volume

21

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

45-48

1 reference

17 December 2017

WHO-EORTC classification for cutaneous lymphomas

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Identification of a receptor for the morphogen retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903103980

10.3109/09546630903103980

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017